Quantitative assessment of thrombus burden predicts the outcome of treatment for venous thrombosis: A systematic review

American Journal of Medicine

Volumn 118, Issue 5, 2005, Pages 456-464

  Hull, Russell D ^a   Marder, Victor J ^b   Mah, Andrew F ^b   Biel, Rita K ^b   Brant, Rollin F ^b  

^a FOOTHILLS HOSPITAL   (Canada)

^b NONE

Author keywords

Quantitative clot burden measurement; Systematic review; Treatment of venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; BEMIPARIN; CERTOPARIN; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; REVIPARIN;

ANTICOAGULANT THERAPY; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DOPPLER ECHOGRAPHY; HUMAN; INFORMATION RETRIEVAL; MEDLINE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; REVIEW; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; THROMBUS; TIME SERIES ANALYSIS; TREATMENT OUTCOME; VALIDATION PROCESS; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 18144384256     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.01.025     Document Type: Article

References (32)

1. R.D. Hull, G.E. Raskob, R.F. Brant The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy the emerging theme of delayed recurrence Arch Intern Med 157 1997 2317 2321
2. M.W. Mewissen, G.R. Seabrook, M.H. Meissner, J. Cynamon, N. Labropoulos, S.H. Haughton Catheter-directed thrombolysis for lower extremity deep venous thrombosis report of a national multicenter registry Radiology 211 1999 39 49
3. H.K. Breddin, V. Hach-Wunderle, R. Nakov, V.V. Kakkar CORTES Investigators Effects of low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis N Engl J Med 344 2001 626 631
4. V.J. Marder, R.L. Soulen, V. Atichartakarn Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy J Lab Clin Med 89 1977 1018 1029
5. J. Ninet, P. Bachet, P. Prandoni A randomised trial of subcutaneous low-molecular-weight heparin (CY216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis Thromb Haemost 65 1991 251 256
6. S. Lopaciuk, A.J. Meissner, S. Filipecki Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis a Polish multicenter trial Thromb Haemost 68 1992 14 18
7. V.V. Kakkar, D.A. Hoppenstead, J. Fareed Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosis Blood 99 2002 1965 1970
8. T.M. Hyers, G. Agnelli, R.D. Hull Antithrombotic therapy for venous thromboembolic disease. ACCP Consensus Report Chest 114 suppl 5 1998 561S 578S
9. L.R. Dolovich, J.S. Ginsberg, J.D. Douketis, A.M. Holbrook, G. Cheah A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism Arch Intern Med 160 2000 181 188
10. M.K. Gould, A.D. Dembitzer, R.L. Doyle, T.J. Hastie, A.M. Garber Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis Ann Intern Med 130 1999 800 809
11. A.D. Oxman, G.H. Guyatt Validation of an index of the quality of review articles J Clin Epidemiol 44 1991 1271 1278
12. F.A. McAlister, H.D. Clark, C. van Walraven The medical review article revisited has the science improved? Ann Intern Med 131 1999 947 951
13. D. Moher, D.J. Cook, S. Eastwood, I. Olkin, D. Rennie, D.F. Stroup QUOROM group Improving the quality of reports of meta-analyses of randomized controlled trials the QUOROM statement Lancet 354 1999 1896 1900
14. K.F. Schultz, I. Chalmers, R.J. Hayes, D.G. Altman Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials JAMA 273 1995 408 412
15. J. Lau, P. Ioannidis, C.H. Schmidt Quantitative synthesis in systematic reviews Ann Intern Med 127 1997 820 826
16. G. Agnelli, C. Becattini, T. Kirschstein Thrombolysis vs. heparin in the treatment of pulmonary embolism. A clinical outcome-based meta-analysis Arch Intern Med 162 2002 2537 2541
17. J.F. Jekel, J. Elmore, D.L. Katz Epidemiology, Biostatistics, and Preventive Medicine 1997 WB Saunders Philadelphia, Pennsylvania 95 114
18. M.J. Bradburn, J.J. Deeks, D.G. Altman Metan - an alternative meta-analysis command Stata Technical Bulletin 44 1998
19. S.G. Thompson, S.J. Sharp Explaining heterogeneity in meta-analysis a comparison of methods Stat Med 18 1999 2693 2708
20. P. Prandoni, A.W.A. Lensing, H.R. Buller Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis Lancet 339 1992 441 445
21. J. Harenberg, J.A. Schmidt, K. Koppenhagen, A. Tolle, M.V. Huisman, H.R. Buller EASTERN Investigators Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis Thromb Haemost 83 2000 652 656
22. C.M. Kirchmaier, H. Wolf, H. Schafer, B. Ehlers, H.K. Breddin Certoparin-Study group Efficacy of low-molecular-weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis Int Angiol 17 1998 135 145
23. J.A. Gonzalez-Fajardo, E. Arreba, J. Castrodeza Venographic comparison of subcutaneous low-molecular-weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis J Vasc Surg 30 1999 283 292
24. J.N. Fiessinger, M. Lopez-Fernandez, E. Gatterer Once-daily subcutaneous dalteparin, a low-molecular-weight heparin, for the initial treatment of acute deep vein thrombosis Thromb Haemost 76 1996 195 199
25. K. Luomanmaki, S. Grankvist, C. Hallert A multicentre comparison of once-daily subcutaneous dalteparin (low-molecular-weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis J Intern Med 240 1996 85 92
26. P. Lindmarker, M. Holmstrom, S. Granqvist, H. Johnsson, D. Lockner Comparison of once-daily subcutaneous fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis Thromb Haemost 72 1994 186 190
27. G. Bratt, W. Aberg, M. Johansson, E. Tornebohm, S. Granqvist, D. Lockner Two daily subcutaneous injections of fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis (DVT) Thromb Haemost 64 1990 506 510
28. V.V. Kakkar, M. Gebska, Z. Kadziola, N. Saba, P. Carrasco Bemiparin Investigators Low-molecular-weight heparin in the acute and long-term treatment of deep vein thrombosis Thromb Haemost 89 2003 674 680
29. J. Harenberg, K. Huck, H. Bratsch Therapeutic application of subcutaneous low-molecular-weight heparin in acute venous thrombosis Haemostasis 20 suppl 1 1990 205 219
30. G. Simonneau, B. Charbonnier, H. Decousus Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis Arch Intern Med 153 1993 1541 1546
31. A. Gomez-Outes, R. Lecumberri, A. Lafuente-Guijosa Correlation between thrombus regression and recurrent venous thromboembolism. Examining venographic and clinical effects of low-molecular-weight heparins: A meta-analysis J Thromb Haemost 2 2004 1581 1587
32. P. Prandoni, A.W.A. Lensing, M.H. Prins Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism Ann Intern Med 137 2002 955 961